Meso Emerging Active

Rischi di astinenza dei farmaci GLP-1

Nuova narrativa con copertura limitata — ancora in formazione.

Punteggio
0,2
Velocità
▲ 0,0
Articoli
4
Fonti
3

Cronologia del Sentiment

Cronologia degli Eventi

Mar 21, 2026
GLP-1 drugs are changing how Americans eat. Food companies are racing to … Neutral
Mar 19, 2026
1 Reason I'm Never Selling Novo Nordisk Stock Bullish
Mar 18, 2026
This Promising GLP-1 Drug Could Give Novo Nordisk Investors Renewed Hope for … Bearish

Articoli Correlati

1 Reason I'm Never Selling Novo Nordisk Stock

Nasdaq · Mar 19, 2026

This Promising GLP-1 Drug Could Give Novo Nordisk Investors Renewed Hope for the Stock

Yahoo Finance · Mar 18, 2026

Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says

CNBC · Mar 18, 2026

Cronologia

Prima apparizioneMar 18, 2026
Ultimo aggiornamentoMar 18, 2026